Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Participant Recruitment and Screening

Posted on By

Standard Operating Procedure for Recruiting and Screening Participants in Clinical Research

Purpose

This SOP outlines the procedures for recruiting and screening participants in clinical trials and clinical studies. The goal is to ensure that recruitment and screening are conducted efficiently, ethically, and in compliance with study protocols and regulatory requirements.

Scope

This SOP applies to all personnel involved in participant recruitment and screening, including principal investigators, clinical research coordinators, and other study team members.

Responsibilities

  • Principal Investigator (PI): Provides oversight and ensures ethical recruitment and screening practices.
  • Clinical Research Coordinators: Conduct recruitment and screening activities in accordance with study protocols.
  • Study Team: Assists in recruitment and screening as required by the study protocol.
See also  Clinical Studies: SOP for Participant Follow-Up and Retention

Procedure

  • Recruitment Plan:
    • Develop a recruitment plan based on the study protocol, including inclusion and exclusion criteria.
    • Define recruitment strategies such as advertising, referrals, and outreach programs.
    • Ensure recruitment materials are accurate, clear, and approved by the ethics committee.
  • Participant Recruitment:
    • Execute recruitment strategies to attract potential participants.
    • Provide information about the study and answer questions from potential participants.
    • Schedule screening appointments for interested participants.
  • Screening Process:
    • Conduct screening according to the study protocol and inclusion/exclusion criteria.
    • Review participant medical history, medications, and perform required assessments.
    • Document screening results, including eligibility determinations.
  • Enrollment:
    • Obtain informed consent from eligible participants.
    • Complete enrollment and begin the study according to the protocol.
    • Maintain records of
recruitment and screening activities.

Abbreviations Used

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • ICF: Informed Consent Form

Documents

  • Recruitment plan
  • Recruitment materials (e.g., advertisements, flyers)
  • Screening logs and forms
  • Eligibility assessment forms
  • Informed consent forms

References

  • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
  • Institutional policies and procedures
  • Ethics committee regulations

SOP Version

Version: 1.0

See also  SOP for Study Closure and Reporting
Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

Post navigation

Previous Post: Clinical Studies: SOP for Participant Recruitment and Screening
Next Post: SOP for Data Collection and Management

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version